Published on
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has recommended use of the FluMist Quadrivalent nasal spray influenza vaccine in the next influenza season. Starting 2 years ago, healthcare providers have been urged to not use that vaccine because the CDC said there was a lack of efficacy in preventing influenza. However, the new ACIP recommendation comes on the heals of a U.S. study in young children that found vaccines containing a 2017–2018 strain of H1N1 influenza virus performed better than the 2015–2016 strain. Whether having a “pain free” option again will encourage more people to get vaccinated next year remains to be seen.
In the Midst of a Bad Season, CDC Reverses Course on Nasal Flu Vaccine—for Next Year